Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease

Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening

(2020) Ting Zhang et al.   Protein & Cell

Methamphetamine-induced alterations in intestinal mucosal barrier function occur via the microRNA-181c/ TNF-α/tight junction axis

(2019) Simin Shen et al.   TOXICOLOGY LETTERS

Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now?

(2018) Michael F. Vaezi et al.   Clinical Gastroenterology and Hepatology

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use

(2018) Yuji Naito et al.   DIGESTION

Pathophysiology of Gastroesophageal Reflux Disease

(2018) Jan Tack et al.   GASTROENTEROLOGY

Elevated methane levels in small intestinal bacterial overgrowth suggests delayed small bowel and colonic transit

(2018) Jaspreet Suri et al.   MEDICINE

Microbiota transplantation: concept, methodology and strategy for its modernization

(2018) Faming Zhang et al.   Protein & Cell

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

(2018) Benjamin H. Mullish et al.   JOURNAL OF HOSPITAL INFECTION

On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis

(2018) Zubair Khan et al.   Gastroenterology Research and Practice

Proton Pump Inhibitor–Refractory Gastroesophageal Reflux Disease

(2018) Rena Yadlapati et al.   MEDICAL CLINICS OF NORTH AMERICA

Fecal microbiota transplantation for patients with irritable bowel syndrome

(2018) Wenting Wen et al.   MEDICINE

The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association

(2017) Daniel E. Freedberg et al.   GASTROENTEROLOGY

Long-term proton pump inhibitors and risk of gastric cancer development after treatment forHelicobacter pylori: a population-based study

(2017) Ka Shing Cheung et al.   GUT

World Gastroenterology Organisation Global Guidelines

(2017) Richard Hunt et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn’s disease complicated with inflammatory mass

(2017) Zhi He et al.   Scientific Reports

Outcomes and prognostic factors of fecal microbiota transplantation in patients with slow transit constipation: results from a prospective study with long-term follow-up

(2017) Chao Ding et al.   Gastroenterology Report

The natural history of gastro-esophageal reflux disease: a comprehensive review

(2016) E. Savarino et al.   DISEASES OF THE ESOPHAGUS

Early prediction of intestinal mucosal barrier function impairment by elevated serum procalcitonin in rats with severe acute pancreatitis

(2016) Hong-chang Li et al.   PANCREATOLOGY

Proton pump inhibitors affect the gut microbiome

(2015) Floris Imhann et al.   GUT

Proton pump inhibitors alter the composition of the gut microbiota

(2015) Matthew A Jackson et al.   GUT

Fecal Microbiota Transplantation in Inflammatory Bowel Disease

(2014) Gianluca Ianiro et al.   MEDICINE

Molecular Pathways: Pathogenesis and Clinical Implications of Microbiome Alteration in Esophagitis and Barrett Esophagus

(2012) L. Yang et al.   CLINICAL CANCER RESEARCH

Role of E-cadherin in the Pathogenesis of Gastroesophageal Reflux Disease

(2011) Biljana Jovov et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

(2010) Y. Kinoshita et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS